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Dithiocarbamates  and iron chelators were recently considered for the treatment of AIDS and 
neurodegenerative  diseases. In this study, we show that dithiocarbamates  and metal chelators 
can potently block the activation of nuclear factor KB (NF-KB), a transcription  factor involved 
in human immunodeficiency virus type 1 (HIV-1) expression, signaling,  and immediate early 
gene activation during inflammatory processes. Using cell cultures,  the pyrrolidine derivative 
of dithiocarbamate (PDTC) was investigated in detail. Micromolar amounts of PDTC reversibly 
suppressed the release of the inhibitory subunit It(B from the latent cytoplasmic form of NF-KB 
in cells treated with phorbol ester, interleukin 1, and tumor necrosis factor c~ Other DNA binding 
activities and the induction of AP-1 by phorbol ester were not affected. The antioxidant PDTC 
also blocked the activation of NF-KB by bacterial lipopolysaccharide (LPS), suggesting  a role 
of oxygen radicals in the intracellular signaling of LPS. This idea was supported by demonstrating 
that treatment of pre-B and B cells with LPS induced the production of O2 - and H202.  PDTC 
prevented specifically the KB-dependent transactivation  of reporter genes under the control of 
the HIV-1 long terminal repeat and simian virus 40 enhancer. The results from this study lend 
further support to the idea that oxygen radicals play an important role in the activation of NF-KB 
and HIV-1. 
W 
~hen cells are exposed to life-threatening  conditions, 
many genes are newly activated with products that 
serve to warn other cells and defend the organism.  For in- 
stance, UV light, 3' rays, elevated temperature, oxygen rad- 
icals, pro- and eukaryotic  parasites, viruses,  and cytokines 
(which are released by pathogen-stimulated cells) can elicit 
such an emergency program of gene activation. Among the 
newly synthesized proteins are cytokines, such as IFN-B and 
TNF, cell surface receptors with immunological functions, 
acute phase proteins,  and growth factors. This kind of re- 
sponse is not restricted to cells of the immune system but 
can probably occur in most cell types of the organism.  One 
would expect that there are multiple receptors for pathogens 
that elicit various intracellular  signal transducing systems. 
These finally reach many different transcription factors in the 
nucleus which then activate the genes encoding signaling and 
defense proteins. 
It was thus surprising to find that one multiprotein complex, 
the nuclear factor K B (NF-KB),  1 has apparently specialized 
1 Abbreviations  used  in  this  paper:  DDTC,  diethyl  derivative  of dithio- 
carbamate; DOC, sodium deoxycholate; EMSA, electrophoreric mobility 
shift assays; NAC, N-acetyl-L-cysteine;  PDTC, pyrrolidine dithiocarbamate; 
PGA,  pyroglutamic  acid;  ROI,  reactive oxygen intermediates;  SOD, 
superoxide dismutases. 
during evolution in the reception of many diverse pathogenic 
signals and, also, in cytoplasmic/nuclear  signal transduction 
and immediate early activation of a multitude of genes en- 
coding signaling and defense proteins (for review, see refer- 
ences 1 and 2). Pathogenic signals lead to the activation of 
a preexisting, cytoplasmic form of NF-KB that, after translo- 
cation into the nucleus, initiates transcription of genes in syn- 
ergy with other factors. The activation of NF-KB has its mo- 
lecular basis in the release of an inhibitory subunit, called 
IKB, from a heterodimer of two DNA binding sub.units, pS0 
and p65 (3, 4). It is a puzzling observation that this reaction 
can be triggered by very diverse agents. Some of them, such 
as phorbolesters,  induce protein kinase C  (PKC).  But this 
kinase seems not to be a universal activator because other 
NF-KB-activating agents, such as TNF and IL-1, do appar- 
ently not require PKC (5,  6). 
We and others have recently observed that the activation 
of NF-KB can be blocked by thiol compounds (7-9). 20-30 
mM N-acetyl-I.-cysteine (NAC) (8, 7) or 0.5 mM t-cysteine 
(9) could block NF-KB induction upon PMA or TNF treat- 
ment of cells. The chemical basis for the inhibiting effect of 
the compounds seemed to lie in an oxygen radical-scavenging 
effect of the thiol groups. An involvement of reactive oxygen 
intermediates  (ROI) in the effects of PMA and TNF was 
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and release of H202 and O2-  when cells are stimulated with 
PMA or TNF (11-15).  More direct evidence that ROI play 
a role in the activation of NF-KB came from the demonstra- 
tion  that  exposure  of T  cells  to  micromolar  amounts  of 
H202  can  activate  the  transcription  factor  and  the  rB- 
dependent induction of a reporter gene under control of the 
HIV-1 LTR (7).  Subsequently, it was shown that induction 
of NF-rB by many other inducers,  such as cycloheximide, 
double-stranded RNA,  bacterial LPS,  Ibl,  lectin,  calcium 
ionophore (7), and the viral transactivator tax from HTLV-1 
(R. Schreck, R. Grassmann, B. Fleckenstein, and P. Baeuerle, 
manuscript in preparation), was also blocked by thiol reagents, 
suggesting that ROI serve as an important and widely used 
messenger in the activation  of NF-KB (16). 
The metal-chelating properties of the diethyl derivative of 
dithiocarbamate (DDTC) were exploited for decades for the 
treatment  of metal poisonings  (17 and references  therein). 
In 1983, DDTC was administered for the first time to AIDS 
patients (18).  In the meantime,  many clinical trials showed 
that the drug can retard the onset of AIDS symptoms in some 
but not all infected individuals (19-21 and references therein). 
The molecular basis for this activity of DDTC is unknown, 
but thought to be related to the previously described radical- 
scavenging,  antioxidative properties ofdithiocarbamates (22- 
24). The recent observation that exposure to oxidative stress 
of cell cultures latently infected with HIV-1 induces activa- 
tion of the provirus and viral replication (7, 25, 26) would 
explain the antiviral  effect of antioxidants.  Also consistent 
with an important role of oxidative stress in the progression 
of AIDS are the observations that HIV-infected patients have 
decreased levels of plasma cysteine (27, and reviewed in refer- 
ence 28), and that antioxidants, such as vitamin C (29), NAC 
(30), and glutathione (and esters) (31), suppress HIV-1 repli- 
cation. Because NF-KB is an important activator of the HIV-1 
provirus (32, 33) and is specifically  activated upon oxidant 
stress (7), we have tested here whether the transcription factor 
is a target  for dithiocarbamates. 
Other agents that can interfere with production of oxygen 
radicals in intact cells are desferrioxamine (34-37) and o-phen- 
anthroline  (38). The chelators can complex Fe  3+ and other 
metal ions that,  by the Fenton reaction,  participate  in the 
production of hydroxyl radicals  from HzO2. A recent study 
suggests that desferrioxamine  may slow down clinical progres- 
sion of the dementia associated with Alzheimer's disease (39). 
For these reasons, we also tested nonsulfur metal chelators 
for inhibition  of NF-rB  induction. 
Using cell culture experiments, dithiocarbamates and metal 
chelators are shown here to be potent inhibitors  of NF-KB 
activation. Three dithiocarbamate derivatives and two metal 
chelators could inhibit NF-KB induction at an up to two orders 
of magnitude lower concentration than the sulhydryl com- 
pound NAC.  Pyrrolidine dithiocarbamate  (PD'IC)  seemed 
to be suited best for cell culture experiments.  The effect of 
PDTC seemed to be specific for NF-KB,  and the drug was 
active with  all  NF-KB  inducers and cell lines  tested.  Early 
withdrawal of PDTC did not affect the responsiveness  of cells, 
but overdosage or chronic  treatment  desensitized the cells 
for the inhibiting  effect of PDTC.  The  specific  and dose- 
dependent inhibitory effect of PDTC on the inducibility of 
NF-KB DNA binding was reflected in the drug's effect on 
the  transactivation  of various  reporter  genes.  While  ~cB- 
dependent gene induction was inhibited by micromolar con- 
centrations of PDTC, the basal activities of reporter constructs 
were virtually unaffected by the drug. Because PDTC did not 
affect the level of the cytoplasmic NF-rB-IrB complex and 
could not interfere with DNA binding or nuclear uptake of 
NF-KB, it most likely blocked a reaction required for release 
of IrB from NF-rB in intact cells.  This reaction seemed to 
require metal ions and hydroxyl radicals.  Superoxide radicals, 
which are rapidly eliminated in cell lines overexpressing Mn- 
dependent superoxide dismutase (MnSOD),  seem not to be 
directly involved in NF-rB activation.  PDTC also blocked 
the activation of NF-KB by LPS,  suggesting that the endo- 
toxin induced oxidative stress in cells. This was directly demon- 
strated by measuring  the production  of H202 and O2-  in 
pre-B and B  cells  stimulated with  LPS. 
Materials  and Methods 
Cell Culture and Treatments.  Jurkat  T  (subclone JR,  kindly 
provided by Dr.  Th. I-Ifinig, Wiirzburg, Germany), BJA-B, and 
MCF-7 cell lines, and an EBV-transformed human B cell line, were 
grown  in  tLPMI  1640 supplemented  with  10%  FCS  and  1% 
(wt/vol) PenicillinAtreptomycin (all purchased from Gibco Labora- 
tories, Grand Island, NY) 70Z/3.12 cells (TIB 158; American Type 
Culture Collection, I~ckville, MD) were cultured in RPMI 1640 
containing 50 #M 2-ME. Ltk- cells were kept in DME containing 
10% FCS and 1% antibiotics. TNF-ce and IL-13 were purchased 
from Genzyme (Boston, MA), and LPS, PHA, NAC, pyrrolidine, 
glutathione,  PDTC,  DDTC, disulfiram, desferrioxamine, FeC13, 
o-phenanthroline,  pyroglutamic  acid (PGA), cycloheximide, and 
PMA were from Sigma Chemical Co. (St. Louis, MO). H202 was 
purchased from Merck and 2-ME from Roth. PGA and NAC were 
adjusted to pH 7.4 by addition of 1 N NaOH. LPS, pyrrolidine, 
glutathione, PDTC, and DDTC were dissolved in PBS, and o-phen- 
anthroline in 20% EtOH. Cycloheximide and desferrioxamine were 
dissolved in  H20,  disulfiram in  100% EtOH,  and  PMA  in 
DMSO.  The respective solvents were added to control cultures. 
The use of metal spatulas was avoided. Preincubation periods and 
concentrations  of compounds are indicated in the figure legends. 
Oligonucleotides and Plasmid Constructs.  Oligonucleotides were 
synthesized on a cell synthesizer (A380; Applied Biosystems, Inc., 
Foster City, CA) by the phosphoroamidate  method and purified 
on OPC cartridges (Applied Biosystems, Inc.) according to the in- 
structions  provided by the manufacturer.  The sequences of the 
double-stranded oligonucleotides used to detect the DNA binding 
activities of NF-KB, octamer binding  proteins  (oct),  AP-1/c-Fos 
(TILE),  CRE  binding  proteins,  and  Sp1  were  the  following 
(the  binding  site is  underlined).  NF-rB:  5'-AGCTTGGGCC- 
GGGGAATCCCGCTAAG-3'  (this motif is from the promoter of 
the ltLF-1 transcription factor [40] containing a high atrmaity  binding 
site for NF-rB [R. Schreck and P. Baeuerle, manuscript  in prep- 
aration]);  Oct:  5'-AGCTTTGGGTAATTTGCATTTCTAAG-3'; 
AP-I: 5'-A~~.A'/GAG'I1C,  A~3';  CREB: 
5'-TCGACTGCTGACGTCAGAGGGAGGACTGCAGTCTCCA- 
GCT-Y; Spl: 5'-TCGACCTGGGGCGGGGCAGGAGCT-3'.  The 
1182  Dithiocarbamates  as Potent Inhibitors of NF-KB Activation complementary  strands created 5'-overhanging  ends (Sail or HindlII), 
which allowed labeling by the Klenow polymerase (Boehringer 
Mannheim  Biochemicals, Indianapolis, IN)  using two ot-[32p]  - 
dNTPs (3,000 Ci/mmol) (Amersham Corp., Arlington Heights, 
IL) and the respective other two dNTPs in unlabeled form. The 
labeled DNA probe was purified on push columns (Stratagene 
Corp.). The wild-type and KB mutant forms of the plasmids, called 
here HIV-1-LTR-CAT,  contain HIV-1 sequences  from -453 to +80 
from the transcription start site of the viral genome upstream of 
a CAT reporter gene (32, 41). The plasmid pSVtkCAT contains 
two 72-bp repeats from the SV40 enhancer in front of the tk pro- 
moter (42). 
Electrophoretic  Mobility Shift Assays.  Cytoplasm and nuclear ex- 
tracts were prepared from cultured cells as described (3). Equal 
proportions of cell fractions with 2-8/xg of protein were used in 
the assays. DNA binding conditions for NF-KB and dectrophoretic 
mobility shift assays (EMSAs) were described in detail elsewhere 
(43). Briefly,  binding reactions (20 #1) contained 2/~g poly(dI-dC) 
(Pharmacia Fine  Chemicals,  Piscataway, NJ),  5-10,000 cpm 
(Cerenkov) for 32p-labeled DNA probe (>3,000 Ci/mmol), 1/xl 
buffer D containing 1% (vol/vol) NP-40, 20/~g BSA, and binding 
buffer. Reactions were started by the addition of cell extracts and 
allowed for 30 min before electrophoresis. Samples were analyzed 
on native  4% polyacrylamide  gels. Dried gels were exposed to Kodak 
XK5 film on intensifying screens (DuPont Co., Wilmington, DE) 
for 5-15 h at  -70~ 
Transfect~'ons  and CAT Assays.  Transfections  were performed by 
the DEAE-dextran method according to Pomerantz et al. (44). 107 
cells were washed with PBS and resuspended in Tris-buffered sa- 
line containing 200/xg/ml DEAE-dextran (Pharmacia  Fine Chem- 
icals) and 15 #g/ml of plasmid DNA in a total volume of 1 ml. 
20 h after transfection, aliquots from batchwise-transfected cells 
were incubated with the indicated amounts of PDTC or PGA. 1 h 
later, cells were stimulated for 9 h with a combination of PMA 
(50 ng/ml) and PHA (5 #g/ml; both from Sigma Chemical Co.). 
Cell extracts were prepared by three cycles of freeze-thawing and 
equal amounts of protein determined by the method of Bradford 
(Bio-Rad Laboratories, Richmond, CA) used for CAT assays  (45). 
A reaction mix of 150/~1 contained 20 mM acetyl CoA (Sigma 
Chemical  Co.)  and  0.3  #Ci  14C-chloramphenicol (Amersham 
Corp.). Chloramphenicol acetylation was allowed with 60/xg of 
protein  for 3.5 h  (HIV-1-LTR-CAT) and with 40  #g  for  1 h 
(pSVtkCAT) at 37~  respectively. Transfections  were performed 
in duplicate. Values deviated <10% from the mean. Mock trans- 
fections showed a chloramphenicol conversion of <0.3%. In un- 
stimulated cells, the chloramphenicol  conversion with HIV-1-LTR- 
CAT was 4.2% and the basal conversion of pSVtkCAT was 4.6%. 
SOD-overexpressing Cell Line.  The stable transfection of the 
human breast carcinoma  cell  line MCF-7 with the expression  plasmid 
pExneo-SOD was described  in detail by Kraft (46). Northern anal- 
),sis was performed as described (47), and MnSOD activity in crude 
cell homogenates was determined in native 10% polyacrylamide 
gels by the staining method of Beauchamp and Fridovich (48). 
Determination of H202 and 02-.  H202  released from 2  x  l0  s 
70Z/3 and pre-B EBV-transformed  B cells was determined fluoro- 
metrically  by the peroxidase-catalyzed  oxidation of scopoletin (49). 
Cell cultures contained 40 nM scopoletin and 1 #M peroxidase. 
A SFM-23 fluorimeter (Kontron) was used at an excitation wave 
length of 381 nm. Emission was measured at 436 nm. Plots were 
standardized with H202. O2- released by the cell cultures was de- 
termined by the reduction of  cytochrome  c (50 #M) (50). A double- 
beam photometer (Uvikon 820; Kontron) with automated cuvette 
exchanger was used. Basal  production was measured for 1 h before 
stimulation. The specificity of cytochrome reduction was tested 
by the addition of SOD  (1 /~M). 
Results 
Diverse Thiol Compounds and Metal Chelators Interfere with 
Activation of NF-rdg  We have recently observed that aJurkat 
T cell subclone activates NF-xB when exposed to oxidative 
stress by treatment with H202 (7). H202 can passively cross 
the plasma membrane and, within the cell, is either converted 
by catalases into H20 and 02, or, by the Fenton reaction, 
into hydroxyl radicals (OH-). If the effect of H202 relies on 
the production of OH. radicals, two types of agents should 
be able to prevent the activation of NF-rB: (a) chelators ab- 
sorbing metal ions required for the Fenton reaction, and (b) 
thiol compounds that can effidently  react with radicals. Here, 
metal chelators and noncysteine sulfur reagents were tested 
for inhibition of NF-KB activation. 
NF-rB in a strongly H202-responsive subclone of Jurkat 
T  cells (called JR) was induced by treatment of cells with 
100/zM H202. This is shown by the appearance  in nuclear 
extracts of the DNA binding activity of NF-KB using elec- 
trophoretic mobility shift assays (EMSAs) with a 32p-labeled 
KB  DNA  probe  (Fig.  1 A,  lane  4).  The  induction was 
prevented when 500  U/ml of catalase were present in the 
cell culture medium (data not shown). As shown in Fig.  1 
A  (compare lanes 4 and 5), cells pretreated with 100 #M of 
the iron chelator desferal showed a 70% reduction in their 
capability to activate NF-KB. Other unrelated binding activi- 
ties (characterized  in reference 7) were unaffected. Desferal 
was ineffective  if preloaded with an equimolar amount of 
Fe  3+  (Fig.  1, lane 6),  suggesting that the inhibiting effect 
relied on the iron chelating property of the agent. Also, 100 
/xM o-phenanthroline,  a chelator with high affinity  for copper 
ions, gave a strong inhibition of the activation of NF-KB by 
H202  (Fig.  1 A, compare lanes 9  and 10). 
Under the same conditions, 30 mM NAC gave only a par- 
tial inhibition of NF-tcB activation (Fig.  1 B, compare lanes 
I  and 5).  14 mM 2-ME had a much stronger effect (Fig.  1 
B, lane 2), but was also ineffective at concentrations <1 mM 
(data not shown). Glutathione (10 mM) barely suppressed 
NF-rB activation, most likely, because it is not taken up very 
well by cells (lane 3).  DDTC gave a very strong inhibition 
of NF-rB activation (lane 4). DDTC, disulfiram (a disulfide- 
linked form of DDTC), and PDTC were tested at lower con- 
centrations. At 100 #M, all three dithiocarbamates potently 
blocked the induction of NF-KB, while nonspecific DNA 
binding activities were barely influenced by the agents (Fig. 
1 B, lanes 7-9). Because DDTC and disulfiram caused an in- 
crease in the pH of the culture medium, long-term treat- 
ments of cell cultures could not be performed with these two 
agents (for toxicity of the two agents in cell culture, see ref- 
erence 51). We therefore concentrated on characterizing the 
pyrrolidine derivative PDTC, which did not detectably change 
the pH of the culture medium. 
Pyrrolidine alone and PGA, a cyclic molecule structurally 
related to PDTC, had no inhibitory effect on the activation 
of NF-xB in cells, even at a concentration of 10 mM (Fig. 
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activation of NF-r.B by HzO2. Cells of the Jurkat T cell subclone  JR were 
stimulated with 100-150 #M H202 for 1 h in the absence and presence 
of the indicated concentrations of compounds. Nuclear extracts were pre- 
pared and equal amounts of protein analyzed for rB-spedfic DNA binding 
in EMSAs using a 32p-labeled  DNA probe (see Materials and Methods). 
Fluorograms of native gels are shown. The H202-inducible complex (filled 
arrowhead) was characterized in detail earlier (7). The unbound  DNA probe 
is indicated by an open arrowhead. Faster migrating complexes were not 
specific. (A) The effect of metal chelators. As indicated on top of the lanes, 
cells were preincubated with 100 #M desferrioxamine for 17 h (desferal; 
left)  or with 100 #M o-phenathroline for 2 h  (right).  (B) The effect of 
thiol compounds. Cells were pmincubated  for 2.5 h with compounds having 
a single SH group,  such as 2-ME, glutathione and NAC, and DDTC at 
the indicated concentrations  (left). PDTC,  DDTC, and disulfiram were 
tested at a concentration of 100 #M during a 1.5 h-preincubation period 
(right). The effects of pyrrolidine and PGA on activation of NF-rB were 
tested between 0.1 and 10 mM, as indicated. 
1 B, lanes 10-I5),  suggesting that the dithiocarboxy group 
was responsible for the activity of PDTC. The observation 
that metal chelators and chemically  diverse sulfur compounds 
inhibit the activation of NF-rB indicates that the production 
of hydroxyl radicals from H202 via the Fenton reaction was 
required for activation of NF-rB in intact cells. 
PDTC Shows a Biphasic Dose-Response Curve.  Stimulation 
ofJurkat T cells with human TNF-c~ strongly induced the 
DNA binding and nuclear appearance of NF-rB (Fig. 2 A, 
compare lanes 2 and 4;  see reference 52).  Calls  treated for 
1 h with PDTC before stimulation with TNF showed a dose- 
dependent suppression of the appearance of NF-rB activity 
in nudear extracts. 10/zM PDTC reduced the gB-specific  signal 
by 40% (lane 5) and treatment with 100/zM PDTC resulted 
in a complete inhibition; the signal was reduced to the back- 
ground level observed in uninduced cells (Fig. 2 A, compare 
lanes 2 and 6).  At concentrations of PDTC >500/zM,  the 
inhibitory effect was partially relieved  (Lanes 7-9). 5 mM PDTC 
was only as efficient as 10/zM PDTC in preventing the acti- 
vation of NF-gB.  Cells treated with 5 mM PDTC showed 
a pattern of DNA binding activities  that was not distinct 
from that of control cells stimulated with TNF (Fig. 2 A, 
compare lanes 4 and 9). This suggests that PDTC is specific 
and did not simply inhibit the DNA binding activity of NF- 
rB, induced proteolysis,  or led to a desintegration of cells. 
It is also unlikely that PDTC blocked TNF binding to its 
receptor. 1 mM PDTC alone could not induce NF-rB binding 
activity (Fig.  2 A,  lane 3). 
We tested the toxicity of PDTC in cell cultures. Jurkat 
cells were incubated for up to 24 h with various concentra- 
tions of PDTC, and the number of trypan blue--excluding 
calls was determined. At concentrations between 10 and 250 
/~M of PDTC, the number of living ceils stayed constant for 
at least  24 h  (Fig.  2 B).  There was,  however,  no increase, 
as observed with control ceils. The stagnation in cell number 
in the presence of PDTC was most likely due to an arrest 
in ceil cycle rather than cdl death because there was no in- 
crease in the number of trypan blue-stained cells. Only a 24-h 
incubation in the presence of 0.5 mM PDTC resulted in a 
reduction of cell number. These results show that cells can 
be kept alive for at least 24 h within a dosed cell culture 
system at concentrations of PD'IC that are optimal for inhi- 
bition of NF-rB. 
PDTC Is a Specific Inhibitor.  The specificity of PDTC was 
tested by assaying nudear extracts from PDTC-treated Jurkat 
cells for the DNA binding activity of other transcription 
factors. Treatment of Jurkat calls with PMA and the lectin 
PHA induced the binding of NF-rB (Fig. 3, compare lanes 
1 and 2), which was potently blocked by 100/zM PDTC (lane 
3). In the same extracts, the induction of AP-1 by PMA was 
detected by assaying with a TILE probe (Fig. 3, compare lanes 
4 and 5).  The newly induced protein-DNA complex was 
specific, as it was the only complex competed for by an excess 
of unlabded TILE probe (data not shown). PDTC could not 
prevent the induction of the AP-1 binding activity (Fig. 3, 
lane 6), indicating that PDTC did not interfere with other 
PKC-regnlated events  in  intact  cells. PDTC  had  also  no 
significant  influence on the binding activity of oct-1  (lane 
9) and proteins binding to a cAMP-response element (CRE; 
lane 12) and the GC-rich binding motif  of Spl (lane I5). Also, 
various nonspecific DNA binding activities detected by the 
various DNA probes were not affected by a treatment of cells 
with 100/~M PDTC. A single nonspecific activity binding 
to the TRE probe seemed to be impaired upon stimulation 
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PDTC effects. (A) The inhibiting 
effect  of  PDTC on the TNF-induced 
NF-t~B activation. Jurkat  T  cells 
were  preincubated  for 1.5 h with the 
indicated concentrations of PDTC 
followed by stimulation with re- 
combinant  human  TNF-c~ (270 
U/ml). For details, see legend  to Fig. 
1. The filled arrowhead (left)  indi- 
cates the position of TNF-induced 
NF-r,B, the small arrows  indicate  the 
positions of  nonspecific  binding ac- 
tivities, and the open arrowhead  in- 
dicates the  position  of unbound 
DNA probe. A quantitation of the 
inhibiting effect of PDTC on the 
TNF-induced  gB-binding  activity  is 
shown on the right. The band cor- 
responding to  the  NF-gB-DNA 
complex  was excised  from the dried 
gel and the 32p radioactivity deter- 
mined by Cerenkov counting. The 
value obtained in lane 4 was set to 
0%  inhibition.  (B) The effect of 
PDTC on cell viability.  Jurkat cell 
cultures were treated for the indi- 
cated periods of time with the in- 
dicated concentrations of PDTC. 
Total cell numbers were counted 
microscopically by phase contrast 
and the number of  dead cells  deter- 
mined by trypan blue uptake. 
and PD'I~  treatment (lane 6).  In conclusion,  PDTC seems 
to be a fairly specific inhibitor of the induction  of NF-KB. 
PDTC Blocks  NFqcB Activation  Independently  of  the Inducing 
Agent and Cell Line.  The activity of PDTC was  tested in 
other cell types and with other agents known to induce NF- 
KB. PDTC suppressed the NF-KB induction in Jurkat T  cells 
after TNF-ol or PMA/PHA  treatments (Fig. 4, lanes 5 and 
6). In the mouse pre-B cell line 70Z/3, NF-gB was induced 
by treatments of cells with bacterial LPS, PMA, or IL-1 (Fig. 
4, lanes 8-10).  The strong induction of NF-KB by all three 
agents was suppressed by PDTC to a residual binding activity 
of 10-20%  (lanes II-13),  which was  slightly above the ac- 
tivity of unstimulated  cells  (lane  7).  Unstimulated  mouse 
fibroblasts (Ltk-)  showed an elevated basal activity of NF- 
~B (lane 14), which was augmented three- to fourfold after 
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treatment of cells with PMA or TNF-c~ (lanes 15 and  16). 
Treatment of cells with PDTC reduced the basal as well as 
the induced NF-IcB activity to a very low level (lanes 17-19). 
PDTC was also active with the human monocytic cell line 
Mono-mac-6 stimulated with derivatives of bacterial lipopoly- 
saccharide (R.  Schreck, D. Bevec, P. Baeuerle, and G. Bahr, 
manuscript  in preparation). 
In cell lines derived from mature B  lymphocytes, NF-KB 
can be present in a constitutive form (53).  Unlike in fibro- 
blasts,  the nuclear presence of NF-tcB in B  cells could not 
be completely suppressed  by PD'IC  (Fig.  4,  lane 21).  The 
NF-gB complex was  reduced by ,v50%,  as determined by 
scintillation counting of protein-DNA complexes. This in- 
dicates that the constitutive nuclear NF-IcB in B  cells is,  at 
least in part, kept active by a mechanism distinct from that Fig,re 3.  The effect of PD'I~ on 
other  DNA-binding  activities. 
Jurkat T cells  were pretreated  for I h 
with 100/xM PDTC, as indicated, 
followed by a 3-h stimulation  with 
either PMA (50 ng/ml)/PHA (2.5 
/~g/ml) (lanes 2, 3, 5, 6, 8, and 9), 
or 250 U/ml human TNF-cx (lanes 
11, 12, 14, and 15). Nuclear extracts 
were analyzed by EMSA with 32p. 
labeled  DNA  probes  detecting 
KB-binding activities (KB), AP-1/ 
jun/fos-like  activities (TRE), octa- 
mer binding  proteins (oct), cAMP- 
response element binding  activities 
(CRE), and Sp1 (Sp1). Fluorograrns 
of native gels are shown. Complexes 
tested for specific binding are indi- 
cated by filled  arrowheads. The open 
arrowhead indicates the positions of 
unlabeled DNA probes. 
inducing NF-rB after extracellular  treatments. In conclusion, 
PDTC seems to be a versatile agent allowing interference  with 
the  mobilization  of NF-rB  in  various cell  types. 
The Effect  of  PDTC Is Reversible.  PDTC was added to cul- 
tures  of  Jurkat  T  cells  20  h  before  stimulation  with 
PMA/PHA.  If the  PDTC  was  washed  out  after  1.5  h,  a 
PMA/PHA treatment could strongly induce the nuclear ap- 
pearance  of NF-KB  18.5 h later  (Fig.  5, lane 1).  This shows 
that the PDTC treatment did not irreversibly  inhibit the ac- 
tivation of NF-KB.  Cells pretreated  with  PDTC could still 
respond to PDTC when the same amount of the drug was 
added shortly before the PMA/PHA  stimulus, as shown by 
a strong inhibition of NF-KB activation (lane 2).  However, 
in cells where PDTC was not washed out, the activation of 
NF-xB by PMA/PHA after 18.5 h was barely suppressed (lane 
3).  Moreover,  chronically PDTC-treated cells became com- 
pletely insensitive if additional drug was added shortly be- 
fore PMA/PHA stimulation (lane 4). Very similar results were 
obtained when cells were stimulated with TNF-ot. None of 
the various PDTC treatments could induce NF-KB when no 
PMA/PHA or TNF was added (data not shown). A possible 
explanation for the observed desensitization will be discussed. 
Figu~ 4.  The effect of PDTC on 
cell lines treated with various in- 
ducers  of NF-~B, Jurkat  T  cells 
(lanes I-6), 70Z/3 pre-B cells (lanes 
7-13),  and  mouse  fibroblasts 
(Ltk-; lanes 14-19) were pretreated 
for  1 h with 100/xM PD'IE fol- 
lowed by a 3-h treatment with PMA 
(50 ng/ml) plus PHA (2.5/~g/ml), 
10  /~g/ml  LPS, 50  ng/ml PMA 
alone, 50 U/ml I1:1, or 300 U/ml 
human or mouse TNF-ot, as indi- 
cated on top of the lanes. Human 
B cells  (BJAB;  lanes  20 and 21) were 
treated for 2 h with 100 t~M PD'IE 
without  subsequent  stimulation. 
Nuclear extracts were analyzed on 
EMSA. Fluorograms of native gels 
are shown. The filled  arrowheads  in- 
die.ate the positions of  NF-xB--DNA 
complexes. The open arrowheads  in- 
dicate  the  position  of  unbound 
DNA probe. 
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illustrates the time course of the four experiments shown on the right. 
Jurkat T cells  were treated with 150/~M PDTC for 1.5 h. After that period, 
the culture medium was either exchanged (wash out; lanes I  and 2) or 
not (lanes 3 and 4). 20 h after the first addition (I.) of PDTC, cells were 
stimulated with PMA (50 ng/ml) plus PHA (2.5 #g/m1) for 1 h. 1.5 h 
before stimulation, one dish of pretreated (lane 2) and chronically treated 
cultures (lane 4) received a second time 150 #M PD'IC (2.). No activation 
of NF-KB  was observed in the various control cultures if stimulation with 
PMA/PHA was omitted (data not shown).  Nuclear extracts were ana- 
lyzed by EMSA. A fluorogram of a native gel is shown. The filled arrow- 
head indicates the position of the NF-KB-DNA complex, the open arrow- 
head the position of unbound DNA probe. 
PDTC Suppresses gB-dependent Transactivation.  We trans- 
fected Jurkat T cells with KB-dependent CAT reporter con- 
structs and tested whether PDTC can suppress the induction 
of CAT activity after a PMA/PHA treatment of cells. Both 
reporter constructs are under inducible  control of NF-KB 
binding sites (32, 54-56). Cells transfected with HIV-1-LTR- 
CAT showed a strong increase in CAT activity after a treat- 
ment with PMA/PHA  (Fig. 6,  compare lanes 1 and 2). 
Treatment of cells with 30 and 90/~M PDTC resulted in a 
dose-dependent suppression of the induction of CAT activity 
(lanes 3 and 4).  This effect was in the same concentration 
range as the inhibiting effect of PDTC on NF-KB activation 
seen by EMSA. 30 and 90 #M PGA had no effect (lanes 5 
and 6). Also, with the construct pSVtkCAT, a strong CAT 
enzyme induction was observed after PMA/PHA stimula- 
tion of  Jurkat cells (Fig. 6, lanes 7 and 8) for which, most 
likely, NF-KB is responsible (56). PDTC had an even stronger 
inhibitory effect on the induction of CAT activity with this 
construct (lanes 9 and 10). 
In the presence of 30 and 90/~M PDTC, the basal activity 
of  HIV-1-LTR-CAT  was slightly increased  (Fig. 6, lanes 11-13). 
In a related reporter construct with two mutated KB sites 
(32, 41), which is mainly dependent on three Spl sites for 
basal activity, the levels of CAT activity were virtually un- 
changed if cells were treated with 30 or 90 #M PDTC (lanes 
14 to 16). Also, the basal activity of the pSVtkCAT reporter 
constructs was unaffected by the PDTC treatment of cells 
(lanes 17-19). These data suggest that PDTC is an inhibitor 
of NF-KB-dependent transactivation and does not influence 
gene regulation by various other factors. 
PDT~ Appears to Prevent  the Release  of  lKB  from NtZrdg  The 
inactive cytoplasmic complex of NF-KB and IKB can be dis- 
sociated in vitro by treatment of cytoplasmic fractions with 
sodium deoxycholate (DOC) (57). This allows detection and 
quantitation  of the  NF-KB-IKB complex  by  EMSA.  In 
cytoplasm from unstimulated cells only very low amounts 
of NF-KB activity were detected before a DOC treatment 
(Fig. 7 A, lane 1). The cytoplasmic  NF-KB activity was slightly 
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Figure 6.  The effect of PDTC on 
the transcriptional  activity of var- 
ious reporter genes. Jurkat T cells 
were transfected  with chloramphen- 
icol acetyltransferase  (CAT) reporter 
plasmids controlled by a wild-type 
HIV-1 LTR, a mutant HIV-1 LTR 
in which both NF-KB  binding  sites 
are  altered  (32, 41), and by two 
copies of the 72-bp repeat  of the 
SV40 enhancer (42). 24 h after trans- 
fection,  cultures  were  treated  for 
10 h with the indicated amounts of 
PDTC or PGA.  1 h after addition 
of PDTC or PGA, cells  were treated 
for the remaining 9 h with PMA 
(50 ng/ml) plus PHA (2.5 ng/ml). 
Cell extracts were analyzed  for CAT 
activity as described  in Materials  and 
Methods. Mean values  from two in- 
dependent transfection experiments 
are shown. Deviations were <10%. 
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gB. (A) The effect  of PDTC on the in vitro activation  of cytoplasmic  NF- 
gB-IKB  complex. As indicated  on top, cultures  ofJurkat T cells were left 
untreated (lanes 1 and 6) or preincubated  with 20/~g/ml cycloheximide 
and PDTC (150/~Vl). Where  indicated,  cells  were  stimulated  with 50 ng/ml 
PICA plus 2.5 #g/ml PHA. Cytoplasmic  fractions  from Jurkat T cells 
were analyzed  by EMSA  without  (lanes 1-5) or after  treatment  with DOC 
(lanes 6-10), as described  earlier (57). The flied arrowheads  indicate  the 
positions of NF-~B binding  activities,  the open arrowheads  the position 
of the xB DNA probe. Fluorograms  of native gels are shown. (/3) The 
effect  of PDTC on the DNA binding activity  of NF-gB in vitro. Nuclear 
extracts from PMA/PHA-stimulated  Jurkat cells were incubated in the 
absence (lane I) and presence (lane 2) of I mM PDTC for 30 min and 
analyzed  by EMSA. (C) Kinetics  of the PDTC effect. 70Z/3 pre-B cells 
were stimulated  with 50 ng/ml PMA (lane  3). 250 #M PDTC was added 
enhanced  if  cells  were  treated  with  cycloheximide  or 
PMA/PHA. Cycloheximide  was used to avoid effects coming 
from transcriptional upregulation of NF-gB-IKB in stimu- 
lated T cells (R. Schreck and P. Baeuerle, unpublished obser- 
vation).  NF-gB-IKB  complex  could  still  be  detected  in 
cytoplasm from PDTC-treated cells, as seen by a strong in- 
crease in NF-KB binding activity after DOC treatment (Fig. 
7 A, lanes 8 and 10).  There was no accumulation of active 
NF-KB in the cytoplasm of stimulated cells pretreated in the 
presence of PDTC (Fig. 7 A, lane 5), indicating that PDTC 
did not interfere with nuclear uptake of NF-gB. Only minor 
differences were noted in the amounts of  DOC-activated NF- 
gB between control and stimulated cells, showing that, upon 
stimulation, only small portions of the cytoplasmic NF-KB 
were activated and translocated to the nucleus.  The data are 
consistent with the idea that PDTC prevents a reaction re- 
quired to release IgB from NF-gB in intact cells. 
From the experiment shown in Fig. 2 A, it is already ob- 
vious that PDTC does not interfere with the DNA binding 
activity of NF-KB: even at a concentration of 5 mM PDTC 
in the medium, a TNF treatment could induce NF-KB ac- 
tivity. Also, incubation of a nudear extract from stimulated 
Jurkat cells with 1 mM PDTC could not significantly  inhibit 
the DNA binding of NF-IcB (Fig.  7 B, lane 2). 
We investigated the kinetic of the PDTC effect.  Only if 
pre-B cells were incubated for a minimum of 30 min with 
the agent before stimulation with PMA, a strong inhibitory 
effect was seen (Fig.  7 C, lanes  4  and 5).  50%  inhibition 
was observed if PMA and PDTC were given at the same time 
to the cell culture (Fig. 7 A, lane 6), and none if PDTC was 
added 30  or 60  rain after the PMA stimulus (lanes  7 and 
8). PDTC seemed to be only active if taken up by the cells 
before stimulation. 
Superoxide Radicals Are Not Directly Involved in NF-tcB Acti- 
vation.  A frequent species of oxygen radicals in cells is the 
superoxide  anion, O2-. The radical can be eliminated by su- 
peroxide dismutases (SODs). A previous study indicated that 
the cytotoxic effects of TNF rely on the production of 02- 
because  cell lines overexpressing  MnSOD were more resis- 
tant to the cytotoxic effects of TNF (58). We have used such 
an MnSOD-overexpressing cell line, MCF-7/SOD, and the 
respective parental line, MCF-7, to investigate whether over- 
expression of the same type of superoxide dismutase influences 
the activation of NF-KB by TNF, Ibl, and PMA. As shown 
in Fig. 8 A,  MCF-7/SOD  had high constitutive levels of 
MnSOD mKNA, whereas the mKNA was barely detectable 
in the parental line MCF-7, in which the MnSOD gene is 
under inducible control (59). The high MnSOD mKNA level 
in MCF-7/SOD  cells correlated with an increased  level of 
the enzymatic activity of MnSOD,  as determined by the 
method of Beauchamp and Fridovich (48) (data not shown). 
Additional evidence that MCF-7/SOD cells overexpressed the 
1.5 h (lane 4) or 0.5 h (lane 5) before stimulation,  at the same time (lane 
6), or 0.5 h (lane 7) and 1 h after stimulation  (lane 8) to cells. Lane I, 
unstimulated  cells; lane  2, cells treated  with PDTC without subsequent 
stimulation. Nuclear extracts were prepared and analyzed  by EMSA for 
NF-gB binding activity. 
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overexpression  on the activation of 
NF-~B by various inducers. (A) A 
Northern blot analysis comparing 
the MnSOD  mRNA levels in the 
human  mammary carcinoma cell 
line MCF-7  and a MnSOD-over- 
expressing subclone, called MCF- 
7/SOD, derived from stable trans- 
fection of an MnSOD  expression 
vector (46). Total RNA from 3  x 
10  s cells was used for electropho- 
resis.  As  indicated, filters were 
probed with cDNA fragments de- 
tecting/~-actin or human MnSOD. 
The  positions  of  18S  and  28S 
rRNAs were detected  by methylene 
blue staining and are indicated at the 
right.  (/3) The effect of MnSOD 
overexpression on  the  growth  of 
MCF-7 cells  in the presence  of TNF. 
Parental and  MnSOD-overexpres- 
sing cells (104 cells in 0.1 ml) were 
cultured for 24 h in the presence of 
the  indicated amounts  of recom- 
binant  human  TNF-~x. [3H]Tby- 
midine  incorporated  into  DNA 
within a 6-h pulse was determined 
by liquid scintillation. (C) The effect 
of  MnSOD  overexpression  on 
mobilization of NF-KB. Cultures of 
MCF-7  (lanes I-4) and  MCF- 
7/SOD were treated for 3 h with 
250 U/ml human TNF-o~, 50 U/ml 
Ibl, and 66 ng/ml PMA, and nu- 
clear  extracts  were  analyzed by 
EMSA. A fluorogram  of  a native gel 
is shown. The filled arrowhead in- 
dicates the position of the inducible 
NF-KB-DNA  complex  and  the 
open arrowhead indicates the posi- 
tion of unbound  DNA probe. 
MnSOD  protein  came from  the  observation  that  the  cells 
were more resistant towards the cytotoxic effect of TNF than 
parental  cells  (Fig.  8  B). 
The NF-KB in  the MCF-7/SOD  line was induced  upon 
treatments  with  TNF-cx,  IL-I~, and  PMA  as efficiently as 
that in the control cell line MCF-7  (Fig.  8  C).  We consis- 
tently observed that TNF could more strongly induce  NF- 
KB in the MnSOD  overexpressor.  This might be due to an 
increased production of H202 (and subsequently OH.) from 
O2-  by the activity of the constitutive  MnSOD.  The data 
indicate  that  02-  radicals,  which  are  more  rapidly  elimi- 
nated  in  MnSOD-overexpressing  cells,  are not  directly in- 
volved in the activation of NF-KB by various inducing agents, 
although  they  seem  to be required  for cytotoxic effects of 
TNF.  The inhibiting  effect of metal chelators (see Fig.  1 A) 
suggests rather that hydroxyl radicals originating from H202 
are required. 
LPS Induces the Production of  Reactive Oxygen Intermediates. 
Various cell types can respond to a treatment with TNF, IL-1, 
or PMA with the production of reactive oxygen intermediates 
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also LPS can induce the production of ROI, which would 
provide an explanation for the inhibitory effect of PDTC on 
the NF-KB activation by LPS. The pre-B cell line 70Z/3 is 
strongly responsive to LPS (60) (see Fig. 4). Before stimula- 
tion, cells released only very low amounts of O2-  and H202 
(Fig.  9, A  and B). After addition of 100 ng/ml LPS to cell 
cultures, 70Z/3 pre-B and an EBV-transformed human B cell 
line immediately started  to  produce 02-  (Fig.  9 A)  and 
H202 (Fig. 9 B). The induced signals were specific because 
they were abolished if SOD and catalase, respectively,  were 
added to the culture medium (data not shown). LPS caused 
a between 5- and 10-fold induction in the rate of ROI release 
from these cells. Because H202 is fully and O2-  is partially 
membrane permeable, the reactive oxygen species released into 
the medium upon LPS stimulation are likely to reflect an in- 
tracellular production of the compounds. ROI may thus play 
an important role in the signal transduction by LPS. 
Discussion 
In this study, we tested whether the pyrrolidine derivative 
of dithiocarbamate is useful as inhibitor of NF-KB in cell cul- 
tures. By all criteria tested, PDTC proved to be a potent agent 
allowing interference with the mobilization of NF-KB in in- 
tact cells. (a) PDTC could be used at micromolar concentra- 
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Figure  9.  The effect of LPS on the production of reactive oxygen inter- 
mediates in pre-B and B cells. The release of superoxide anions (A) and 
H202 (B) from 70Z/3 pre-B cells and an EBV-transformed human B cell 
line was determined before and after treatment of cultures with 100 ng/ml 
bacterial LPS (see Materials and Methods). Measurements were performed 
for I  h before LPS addition  without observing  a significant production 
of ROI. The 60-min value represents the mean of three independent  mea- 
surements.  Bars indicate  the SD. 
tions. In this respect, it is approximately 200-fold more po- 
tent than NAC. (b) PDTC was of low toxicity for at least 
24 h when used in cell cultures. (c) PDTC did not inhibit 
the DNA binding activity of all other factors tested, nor the 
inducibility of AP-1 by PMA. (d) PDTC interfered in a specific 
manner with the KB-dependent transactivation of genes. (e) 
PDTC could prevent activation of NF-KB by all inducers and 
in all cell lines tested. The agent might thus find application 
as an experimental tool in cell cultures to study, for instance, 
the role of NF-KB in the induction of genes containing poten- 
tial NF-KB binding sites. 
Because dithiocarbamates are established pharmaceutics, in 
vivo studies also seem possible. The suppressing effect of PDTC 
on the activation of the HIV-1 LTR might stimulate further 
studies exploring effects of DDTC and other derivatives on 
the progression of AIDS. Because NF-KB is involved in T 
cell and macrophage activation and, presumably, in many other 
regulatory processes involving cytokine production, it seems 
also worth testing whether the drugs can suppress  the in- 
duction of NF-KB-controlled cytokine genes in vivo, for in- 
stance,  those encoding the GM-CSF (61) and TNF-o~ (62, 
63). Both GM-CSF and TNF-c~ are potent inducers of HIV-1 
(for review,  see reference 64). 
The Mode of  PDTC Action.  PDTC has at least two chem- 
ical properties. One is a chelating activity for heavy metals, 
which is why the diethyl derivative is used for the treatment 
of heavy metal poisoning. The second is an antioxidative ac- 
tivity of its dithiocarboxy group. Because nonthiol metal che- 
lators, such as o-phenanthroline and desferrioxamine, also can 
inhibit NF-KB activation, it is possible  that the inhibitory 
effect of dithiocarbamates relies on both of its properties. This 
could provide an explanation why dithiocarbamates are much 
more potent than snlfhydryl compounds, which are not as 
strong binding certain metal ions. Alternatively, or in addi- 
tion, PDTC, DDTC, and disulfiram might reach higher or 
longer-lasting intracellular concentrations than the sulfhydryl 
compounds tested so far. This could come from a longer half- 
life within the cell or a more efficient uptake. 
We could not observe that PDTC: (a) Interfered with the 
DNA-binding properties of NF-KB in vitro, (b) blocked the 
nuclear  uptake  of NF-KB, (c)  diminished the  amount  of 
NF-KB-IKB complex in cycloheximide-treated  cells, or (d) in- 
terfered with the release of IKB in the presence of deoxycho- 
late. Thus, the most likely explanation for the effect of PDTC 
is suppression of a reaction required for release of IKB from 
NF-KB in the cytoplasm. Because PDTC could block this reac- 
tion in response to every NF-KB inducer tested so far (see 
also reference 7),  the antioxidant and metal chelator seems 
to interfere with the activity of a common messenger pro- 
duced by apparently different signaling pathways. As proposed 
earlier,  this messenger might be a ROI  (7,  16). 
In this study, we have analyzed in more detail the nature 
of the ROI involved in NF-KB activation. Major species of 
ROI in cells are H202,  OH.,  and 02-  (reviewed in refer- 
ence 65). The abundance of the various ROI species in cells 
can be manipulated, which allows testing to determine which 
one is required for nuclear appearance of activated NF-KB in 
intact cells. H202 can be taken up by cells from the medium; 
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production of OH- from H202 can be specifically blocked 
with low concentrations of metal chelators; and both OH. 
and O5- radicals can be scavenged by thiol reagents, which 
react poorly with H202. Data obtained from these kinds of 
experiments suggest that production of OH. is required for 
activation of NF-KB. The level of O2-, which seems to in- 
crease in response to TNF stimulation of cells (58), was not 
required for NF-KB activation  by TNF,  as shown with a 
MnSOD-overexpressing cell line. Overexpression of MnSOD 
rather stimulated NF-KB induction by TNF, presumably, by 
increasing  the level of intracellular  H202. 
The molecular mechanism by which radicals release IgB 
from NF-KB is not yet understood. One can envision a direct 
damage of IgB by radicals. Because OH. is highly reactive 
and therefore restricted in its diffusion within the cell, an 
in situ production of the radical from H202 seems to be re- 
quired. Alternatively, oxygen radical-sensitive messenger pro- 
teins could be involved, for instance a redox-regulated tyro- 
sine kinase such as Ltk (66), or a specific protease. In that 
context, the analysis of a consensus tyrosine phosphoryla- 
tion site conserved in the NH2 terminus of recently cloned 
IgB proteins  is of great interest  (67, 68). 
The induction of AP-1 by PMA in the presence of PDTC 
suggests that the activity of PKC is not impaired in PDTC- 
treated cells. This idea is strongly supported by our finding 
that, in intact cells, the activity and subcellular redistribu- 
tion of PKC after PMA treatment is virtually unaffected by 
PDTC (R. Schreck and P. Baeuerle, manuscript in prepara- 
tion). Therefore, PKC is most likely not directly involved 
in NF-gB-IKB phosphorylation, which is in contrast to the 
in vitro situation (69). A messenger function of ROI pro- 
duced in response to PMA would provide a plausible expla- 
nation for the inhibiting effect of dithiocarbamates and other 
chemically distinct thiol compounds on the activation  of 
NF-gB by PMA. 
An important observation  might be that overdosage or 
chronic treatment with PDTC could desensitize cells for the 
drug's inhibiting effect. It is conceivable that chronic treat- 
ment with the antioxidant creates a hypoxic status in the cell 
(as during ischemia) under which radical-eliminating enzymes 
are downregulated. This could lead to a more permissive  effect 
of the radicals produced in response to strong inducers, de- 
spite the presence  of the scavenger. Alternatively,  high amounts 
of radical scavengers might also lead to stabilization of rad- 
icals within the cell. Biphasic dose-responses are not unique 
to PDTC. Also, the antioxidants c~-tocopherol, ascorbic acid, 
and rutin show biphasic dose-response curves when tested 
for protection from lipid peroxidation in lymphoid cells (70). 
A consequence of these findings is that long-term incuba- 
tions with PDTC (and perhaps other antioxidants)  or over- 
dosage of the agent should be avoided in cell culture experi- 
ments. These effects might deserve particular  attention in 
dinical trials with antioxidants. 
How Specific Is PDTC?  We cannot exclude the possibility 
that the antioxidant PDTC also affects other transcription 
factors and signal transducing systems. In bacteria,  a tran- 
scriptional activator protein of oxidative stress-inducible  genes, 
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called oxyR, is activated upon direct oxidation (71). Also in 
eukaryotic cells, oxidative stress-responsive  transcription factors 
and messenger proteins unrelated to NF-~B are therefore likely 
to exist. Their activation should also be suppressed by PDTC 
and other antioxidants. An important function of such regula- 
tory proteins might be to allow a cellular response to changes 
in the oxidant state, for instance, by controlling the level of 
radical-eliminating enzymes. An important enzyme involved 
in oxygen radical metabolism is the Mn-dependent mitochon- 
drial SOD. Its mfLNA is transcriptionally induced when cells 
are stimulated with TNF and LPS (58). Because both agents 
activate NF-gB and induce oxidant stress, it is possible that 
NF-gB is involved in the oxidative stress-responsive induc- 
tion of the MnSOD gene. Future studies have to explore a 
role of NF-~B as regulator of ROI homeostasis. 
Recent reports showed that c-Jun mRNA is induced by 
low H202 concentrations  in HeLa cells (72) and in an os- 
teoblastic cell line (73). In HeLa cells, treatment with 250 
/zM H202  for several hours could also elicit AP-1 binding 
activity. Since it is not known that gB-like proteins control 
c-Jun expression and because the H202 effect apparently re- 
quired an intact TRE element in the c-Jun promoter (72), 
the effect was likely to be mediated by c-Jun itself. However, 
in the Jurkat T cell line used in our study, the induction of 
AP-1 by PMA was not influenced by PDTC and we could 
not observe induction of AP-1 by H202 (7). Apart from cell 
type-specific differences, this could indicate that PMA and 
H202 induce AP-1 by distinct intracellular pathways. PMA 
and PKC are thought to activate c-Jun by triggering a de- 
phosphorylation reaction in its DNA binding domain (74). 
The involvement of redox reactions in c-Jun activation are 
currently a matter of debate because it has also been proposed 
that the DNA binding activities of Jun and Fos are down- 
regulated by oxidation of conserved cysteine residues (75). 
ROI and the Intracellular Signaling of LPS.  There is ex- 
perimental  evidence that a variety of NF-KB inducers elicit 
oxidant  stress in  cells. These  include  PMA,  Ibl,  TNF, 
hydrogen peroxide (reviewed in reference 16), 31 rays (76), 
and UV light (77). Here we tested LPS, another strong in- 
ducer of NF-gB, for that property.  Indicative for the induc- 
tion of oxidant stress, two cell lines showed an increased re- 
lease of O5-  and H202  into the medium when triggered 
with low amounts of LPS. LPS is thought to signal intracel- 
lularly by G proteins (78). As indicated by the inhibiting effect 
of pertussis toxin and a decrease in cAMP levels, a Gi-like 
protein is thought to be involved in LPS-induced Ibl produc- 
tion. Because there are no effects of intracellular cAMP levels 
on the activation of NF-KB (6, 79; P. Baeuerle, unpublished 
observation),  we consider it unlikely that GI proteins  and 
cAMP levels are involved in NF-gB activation or induction 
of oxidative stress. Rather, our present data suggest that LPS 
activates a variety of messenger systems. The induction of 
oxidative stress by LPS could come from activation of PKC 
(80). Because no phosphatidyl inositol breakdown was ob- 
served in response to LPS, a breakdown of phosphorylcho- 
line could provide the diacylglycerol necessary for activation 
of PKC.  This situation  was observed in cells treated with 
the NF-KB inducer Ibl  (81). We are grateful to Dr. Georg Arnold for oligonucleotide synthesis, Dr. Marc Muller for providing the 
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